The virus often mutates by simply deleting small pieces of its genetic code. The mutations "disguise" the virus from ...

This is the time of year when updated boosters for COVID-19 are typically available. But this year has been anything but ...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE ...

People in the rapid-decliners group saw a robust rise in post-vaccination IgG (S) antibody titers, followed by a steep ...

Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...

Given all the headlines about the federal policy changes related to the vaccine, we thought it might be good to clarify the ...

Shares in Moderna and BioNTech have imploded since their 2021 peaks, shaving billions of dollars from their founders’ ...

Invivyd, Inc. (NASDAQ:IVVD) is a commercial-stage biopharmaceutical company focused on developing antibody-based therapies ...

The increased Covid activity comes as the US heads into fall respiratory illness season, which tends to bring a rise in cases ...

Any virus or disease discovered has proven to offer its unique set of challenges for the public and health industry.

The coronavirus pandemic has killed over a million people and infected more than 33.5 million worldwide. Here are the latest coronavirus-related developments for September 29: ...

In a chaotic meeting, ACIP voted not to recommend a prescription requirement for Covid-19 vaccines. Some panelists seemed ...